Press release
Impact Of Personalized Medicine On The In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Driver: A Major Catalyst in the Evolution of the In Vitro Diagnostic (IVD) In Cardiology And Neurology Market in 2025
In Vitro Diagnostic (IVD) In Cardiology And Neurology
The expansion of personalized medicine is expected to drive the in vitro diagnostic (IVD) market in cardiology and neurology. Personalized medicine tailors healthcare treatments based on individual genetic and disease profiles, leading to more effective and targeted therapies. This trend is growing due to advances in genomics and regulatory support. In vitro diagnostic tests, particularly in cardiology and neurology, are crucial for providing insights into a patient's condition and guiding customized treatment plans. According to the Personalized Medicine Coalition, 12 new personalized medicines were approved in 2022, representing about 34% of all new therapies. The increasing focus on personalized medicine is boosting the IVD market in these fields.
Get Your In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Report Here:
https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostic-ivd-in-cardiology-and-neurology-global-market-report
What growth opportunities are expected to drive the in vitro diagnostic (ivd) in cardiology and neurology market's CAGR through 2034?
The IVD in cardiology and neurology market will expand from $15.84 billion in 2024 to $17.27 billion in 2025 at a CAGR of 9.0%, fueled by rising cardiovascular and neurological disorders, preventive healthcare, and regulatory support.
The in vitro diagnostic (IVD) in cardiology and neurology market is estimated to reach $24.07 billion by 2029, at a CAGR of 8.7%. Growth is driven by the shift toward personalized medicine, demand for rapid diagnostics, telemedicine expansion, and increasing research efforts. Key trends include liquid biopsy technologies, nanotechnology advancements, remote monitoring adoption, multiplex biomarker panels, innovations in MRI, CT, and PET imaging, and the development of companion diagnostics for cardiovascular and neurological treatments.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15829&type=smp
What are the emerging trends shaping the future of the in vitro diagnostic (ivd) in cardiology and neurology market?
Companies in the in vitro diagnostic (IVD) market for cardiology and neurology are developing AI-enabled epigenetic engines to enhance early disease detection and risk assessment. In February 2023, Cardio Diagnostics Holdings Inc., a US-based biotech company, launched PrecisionCHD, an AI-based blood test for early detection of coronary heart disease (CHD). This test uses integrated epigenetic and genetic biomarkers, providing over 75% sensitivity and offering a non-invasive alternative to traditional diagnostic methods such as exercise stress tests or angiograms.
Which growth-oriented segments of the in vitro diagnostic (ivd) in cardiology and neurology market are leading the industry's development?
The in vitro diagnostic (IVD) in cardiology and neurology market covered in this report is segmented -
1) By Product Type: Instruments, Reagents And Consumables, Software And Services
2) By Technology: Immunoassays, Molecular Diagnostics, Hematology, Other Technologies
3) By End-User: Hospitals, Clinical Laboratories, Other End-Users
Subsegments:
1) By Instruments: Diagnostic Analyzers, Point-Of-Care Devices, Electrophysiology Devices
2) By Reagents And Consumables: Diagnostic Reagents, Test Kits, Assay Consumables
3) By Software And Services: Diagnostic Software, Data Management Software, IVD Consulting And Support Services
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15829
What regions are leading the charge in the in vitro diagnostic (ivd) in cardiology and neurology market?
North America was the largest region in the in vitro diagnostic (IVD) in cardiology and neurology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vitro diagnostic (IVD) in cardiology and neurology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What companies are at the forefront of innovation in the in vitro diagnostic (ivd) in cardiology and neurology market?
Major companies operating in the in vitro diagnostic (IVD) in cardiology and neurology market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostics Incorporated, Hologic Inc., Illumina Inc., Beckman Coulter Inc., Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Instrumentation Laboratory, bioMérieux SA, Natera, Inc., Randox Laboratories Ltd., Fulgent Genetics Inc., DiaSorin S.p.A., Oxford Nanopore Technologies, Fujirebio Diagnostics Inc., Adaptive Biotechnologies, Biocartis Group NV, Agena Bioscience
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=15829&type=smp
What Is Covered In The In Vitro Diagnostic (IVD) In Cardiology And Neurology Global Market Report?
•Market Size Forecast: Examine the in vitro diagnostic (ivd) in cardiology and neurology market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the in vitro diagnostic (ivd) in cardiology and neurology market for a structured understanding.
•Key Players Overview: Analyze major players in the in vitro diagnostic (ivd) in cardiology and neurology market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the in vitro diagnostic (ivd) in cardiology and neurology market.
•Segment Contributions: Evaluate how different segments drive overall growth in the in vitro diagnostic (ivd) in cardiology and neurology market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the in vitro diagnostic (ivd) in cardiology and neurology market.
•Industry Challenges: Identify potential risks and obstacles affecting the in vitro diagnostic (ivd) in cardiology and neurology market.
•Competitive Landscape: Review strategic developments in the in vitro diagnostic (ivd) in cardiology and neurology market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Impact Of Personalized Medicine On The In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Driver: A Major Catalyst in the Evolution of the In Vitro Diagnostic (IVD) In Cardiology And Neurology Market in 2025 here
News-ID: 3925832 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for IVD
In Vitro Diagnostics (IVD) Market
With the watchful use of established and advanced tools such as SWOT analysis and Porter's Five Forces Analysis, this market report has been structured. While preparing this In Vitro Diagnostics (IVD) Market research report, few of the attributes that have been adopted include highest level of spirit, practical solutions, committed research and analysis, innovation, integrated approaches, and most up-to-date technology.
Every possible effort has been taken while researching and analysing…
Companion Animal IVD Market - Guiding the Path to Optimal Health: Empowering Vet …
Newark, New Castle, USA - new report, titled Companion Animal IVD Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Companion Animal IVD market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Companion Animal IVD market. The report offers an overview of…
IVD Market 2021 | Detailed Report
The IVD market research report delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. The IVD report also incorporates the current and future global market outlook in the emerging and developed markets. Moreover, the report also investigates regions/countries expected to witness the fastest growth rates during the forecast period.
The IVD research report also provides insights of different regions that are contributing market growth.…
Liquid Biopsy IVD Market 2021 | Detailed Report
According to Market Study Report, Liquid Biopsy IVD Market provides a comprehensive analysis of the Liquid Biopsy IVD Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample PDF (including full TOC, Tables and Figures) of Liquid Biopsy IVD Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4623688
The report provides a…
Infectious Disease IVD Market – Forecast to 2026
The findings reviewed by GME stated that the Global Infectious Disease In-Vitro Diagnostics Market would grow at a CAGR value of 4.6 percent from 2021 to 2026. The increasing geriatric population is the primary driving factor for the infectious disease in-vitro diagnostics market. Besides, the increasing number of infectious diseases, launch of advanced testing kits and beneficial features attributed by IVDs are propelling growth in the market.
Browse 159 Market…
Asia IVD Market
According to a new report published by Allied Market Research, the Asia Pacific In-vitro diagnostics market was valued at $12.9 billion in 2015, and is expected to reach $19.0 billion registering a CAGR of 5.6% during 2016 to 2022. The report offers a detailed analysis of the key segments, top investment pockets, changing dynamics, market size & estimations, and competitive scenario.
Download Free Sample Report @ https://www.alliedmarketresearch.com/request-sample/1256
The Asia-Pacific IVD market is…
